Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients
暂无分享,去创建一个
[1] L. Skovgaard,et al. Pharmacokinetic studies of neuromuscular blocking agents: Good Clinical Research Practice (GCRP) , 2000, Acta anaesthesiologica Scandinavica.
[2] N. Goudsouzian,et al. Prolonged mivacurium infusion in young and elderly adults. , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[3] R. Farinotti,et al. A855 A pharmacokinetic and dynamic study of mivacurium infusion in elderly patients , 1997 .
[4] F. Donati,et al. Pharmacokinetics of Mivacurium Isomers and Their Metabolites in Healthy Volunteers after Intravenous Bolus Administration , 1997, Anesthesiology.
[5] C. Hull,et al. Pharmacokinetics and Pharmacodynamics of Cisatracurium in Young and Elderly Adult Patients , 1996, Anesthesiology.
[6] C. Lien,et al. Pharmacodynamics and Pharmacokinetics of Cisatracurium in Geriatric Surgical Patients , 1996, Anesthesiology.
[7] L. Skovgaard,et al. Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents , 1996, Acta anaesthesiologica Scandinavica.
[8] P. Rehak,et al. A comparison of mivacurium infusion requirements between young and elderly adult patients. , 1996, European Journal of Anaesthesiology.
[9] J. Hunter,et al. Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function. , 1995, British journal of anaesthesia.
[10] D. Fisher,et al. The Effect of Plasma Cholinesterase Activity on Mivacurium Infusion Rates , 1995, Anesthesia and analgesia.
[11] L. Skovgaard,et al. Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis , 1995, Acta anaesthesiologica Scandinavica.
[12] J. Egmond,et al. Age-Related Differences in Magnitude and Complete Recovery of Mivacurium Induced Neuromuscular Block , 1995 .
[13] T. Sharpe,et al. Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. , 1994, British journal of anaesthesia.
[14] J. Hunter,et al. Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis. , 1994, British journal of anaesthesia.
[15] C. Lien,et al. The Phamtacokinetics and Pharmacodynamics of the Stereoisomers of Mivacurium in Patients Receiving Nitrous Oxide/Opioid/Barbiturate Anesthesia , 1994, Anesthesiology.
[16] L. Skovgaard,et al. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. , 1993, Acta anaesthesiologica Scandinavica.
[17] W. Buzello,et al. Mivacurium: Dose‐Response Relationship and Administration by Repeated Injection or Infusion , 1992, Anesthesia and analgesia.
[18] R. Welch,et al. In Vitro Metabolism of Mivacurium Chloride (BW B1090U) and Succinylcholine , 1989, Anesthesia and analgesia.
[19] T. Heier,et al. The dose-response relationship of mivacurium chloride in humans during nitrous oxide-fentanyl or nitrous oxide-enflurane anesthesia. , 1989, Anesthesiology.
[20] H. H. Ali,et al. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. , 1988, British journal of anaesthesia.
[21] H. H. Ali,et al. The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.
[22] L. Skovgaard,et al. Dose‐response Curves for Vecuronium during Halothane and Neurolept Anaesthesia: Single Bolus versus Cumulative Method , 1985, Acta anaesthesiologica Scandinavica.